vivo T5 5G confirmed with 7,050mAh battery and 144Hz AMOLED.

Vivo is expected to unveil the Vivo X500, X500 Pro, and X500 Pro Max later this month in China. Ahead of the launch, the ...

The Polo Vivo retained the title of SA's best-selling passenger car in August 2026, though the Tiggo 4 Cross was a mere 54 ...

Should you invest in CRISPR Therapeutics (CRSP +0.18%) before the end of the year? The company's shares have slightly underperformed the broader market to date, but the biotech ma ...

Within the utilities sector, short interest at the end of August was spread broadly across the sector, with no single industry emerging as a clear standout or dominating in terms of positioning.

TV y streaming online de la semifinal de la Leagues Cup 2026 Toda la información sobre el Toluca contra León de la Leagues Cup 2026. The Sporting News Leagues Cup 2026: Resultados, posiciones, ...

Typewriter Therapeutics has emerged from stealth with $56 million in Series A funding co-led by AN Venture Partners and RA Capital Management, with participation from ANRI, Gemseki and SBI US Gateway ...

Editas Medicine (EDIT) stays a Hold as EDIT-401 nears trials; preclinical 90%+ LDL-C reduction for HeFH, but dilution and competition loom—read more macroanalysis here.

More foldables are set to use the display technology of the foldable iPhone.

Typewriter Therapeutics secures $56M Series A to develop in vivo CAR T gene therapy using non-viral RNA platform. Discover the breakthrough.

Vivo T5 debuts in India with a 6.83-inch 144Hz AMOLED screen, 7,050mAh battery, and Dimensity 7500 Turbo chip. It starts at ₹34,999 and launches on Sept 9.

The firm said it will stop enrolling a late-stage trial in blood cancers to prioritize a preclinical in vivo T-cell receptor program in solid tumors.